Scientist
GentiBio, Inc
Ashley Landuyt, PhD, is a Scientist at GentiBio, Inc. She received her PhD from the University of Alabama at Birmingham (UAB) in the laboratory of Dr. Craig Maynard studying regulatory T cells (Tregs) and anti-commensal antibodies in the context of inflammatory bowel disease (IBD). Eager to continue work with Tregs and autoimmunity, she joined GentiBio, Inc in 2021, where she specializes in murine models of type I diabetes and IBD.